市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Novavax, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
0.7
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -0.5 |
| 相对估值 | 5.0 |
| 财务健康 | 5.0 |
| 宏观环境 | -0.3 |
| AI Insight | NA |
| 平均 | 0.65 |
|
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 8.78% |
| 机构持股比例 | 57.19% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Shah Capital Management | 30 Sep 2026 | 12,173,481 |
| Coatue Management Llc | 30 Jun 2026 | 3,836,986 |
该时间范围内无数据。
该时间范围内无数据。
投资组合